Immunoisolation techniques for islet cell transplantation

Bibliography

• LACY PE, KOSTIANOVSKY M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 16:35–39.
   PubMed Web of Science ®Google Scholar
• ••The first description of a successfulprocedure to isolate intact and viable islets from pancreatic tissue.
   Google Scholar
• ALEJANDRO R, LEHMANN R, RICORDI C et al.: Long-term function (6 years) of islet allografts in Type 1 diabetes. Diabetes (1997) 46: 1983-1989.
   Google Scholar
• SHAPIRO AMJ, LAKEY JRT, RYAN EA et al.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl. J. Med. (2000) 343:230–238.
   PubMed Web of Science ®Google Scholar
• ••A landmark advance of clinical islet transplantation, utilising a steroid-free regimen.
   Google Scholar
• RYAN EA, LAKEY JRT, RAJOTTE RV et al.: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 50(4):710–719.
   PubMed Web of Science ®Google Scholar
• •Follow-up of the initial results of islet transplantation with a steroid-free regimen.
   Google Scholar
• BRUNICARDI FC, MULLEN Y: Issues in clinical islet transplantation. Pancreas (1994) 9:281–290.
   PubMed Web of Science ®Google Scholar
• WEIR GC, BONNER-WEIR S: Scientific and political impediments to successful islet transplantation. Diabetes (1997) 46:1247–1256.
   PubMed Web of Science ®Google Scholar
• THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl. J. Med. (1993) 329:977–986.
   PubMed Web of Science ®Google Scholar
• ••This was a multi-centre study, whichshowed that strict glycaemic control with intensive insulin treatment could delay the onset and progression of diabetic complications.
   Google Scholar
• KENDALL WF JR, COLLINS BH, OPARA EC: Islet cell transplantation for the treatment of diabetes mellitus. Expert Opin. Biol. Then (2001) 1(1):109–119.
   PubMed Web of Science ®Google Scholar
• IDO Y, VINDIGNI A, CHANG K et al.: Prevention of vascular and neural dysfunction, in diabetic rats by C-peptide. Science (1997) 277:563-566. A, landmark study that showed the biological effects of C-peptide on vascular and neural functions.
   Google Scholar
• LANZA RP, CHICK WL: Transplantation of encapsulated cells and tissues. Surgery (1997) 121:1–9.
   PubMed Web of Science ®Google Scholar
• OPARA EC: The therapeutic potential of islet cell transplants in the treatment of diabetes. Expert Opin. Investig. Drugs (1998) 7(5):1–11.
   PubMedGoogle Scholar
• LANZA RP, CHICK WL: Immunoisolation strategies for the transplantation of pancreatic islets. Ann. NY Acad. Sci. (1997) 831:323–331.
   PubMed Web of Science ®Google Scholar
• REACH G: Bioartificial pancreas. Present state and future prospects. Biorned. Biochlin. Acta (1984) 43(5):569–576.
   Google Scholar
• SIEBERS U, ZEKORN T, BRETZEL RG et al.: Histocompatibility of semipermeable membranes for implantable diffusion devices (bioartificial pancreas). Transplant. Proc. (1990) 22(2):834–835.
   PubMed Web of Science ®Google Scholar
• SIEBERS U, STURM R, RENARDY M et al.: Morphological studies on biocompatibility of artificial membranes for immunoisolated islet transplantation. Donn. Metab. Res. Sapp]. (1990) 25:206–208.
   Web of Science ®Google Scholar
• JAIN K, YANG H, CAI B-R et a/.: Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression. Transplantation (1995) 59:319–324.
   Google Scholar
• TRIVEDI N, KEEGAN M, STEIL et al: Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation (2001) 71:203–211.
   PubMed Web of Science ®Google Scholar
• ELLIOTT RB, ESCOBAR L, GARKAVENKO, 0 et al.: No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant. (2000) 9:895–901.
   Google Scholar
• •A report showing no evidence of transmission of PERVs from pigs to human recipients of encapsulated islet cell xenografts.
   Google Scholar
• SUN Y, MAX, ZHOU D, VACEK I, SUN AM: Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. I Clin. Invert. (1996) 98:1417–1422.
   PubMed Web of Science ®Google Scholar
• ••The first report of long-term viability of encapsulated, pig islet xenografts in a non-human primate.
   Google Scholar
• KENDALL WE COLLINS BH, HOBBS HA, BOLLINGER RR, OPARA EC: Long-term normoglycemia induced by microencapsulated porcine islet xenotransplantation in a diabetic baboon. Acta Chic Austriaca (2001) 33\(Suppl. 174):56.
   Google Scholar
• SOON-SHIONG P, HEINTZ RE, MEREDITH N et al: Insulin independence in Type 1 diabetic patient after encapsulated islet transplantation. Lancet (1994) 343:950–951.
   PubMed Web of Science ®Google Scholar
• ••The first report indicating the viability ofencapsulated islet allografts in a diabetic human subject.
   Google Scholar
• LIM F, SUN AM: Microencapsulated islets as bioartificial endocrine pancreas. Science (1980) 210(4472):908–910.
   PubMed Web of Science ®Google Scholar
• •Introduced the idea of microencapsulation of islets as a viable form of bioartificial pancreas.
   Google Scholar
• WOLTERS GH, FRITSCHY WM, GERRITS D, VAN SCHILFGAARDE R: A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. Appl Biornat. (1992) 3:281–286.
   Web of Science ®Google Scholar
• ••A detailed description of the design for anair-jet bead generator.
   Google Scholar
• HSU BR, CHEN HC, FU SH, HUANG YY, HUANG HS: The use of field effects to generate calcium alginate microspheres and its application in cell transplantation. J. Formos. Med. Assoc. (1994) 93:240–245.
   PubMedGoogle Scholar
• ••Description of the designs for differentbead generators.
   Google Scholar
• HOBBS H, KENDALL W, DARRABIE M, COLLINS B, BRIDGES S, OPARA EC: Substitution of polyornithine for polylysine in alginate microcapsules. Diabetes (2000) 49\(Suppl. 1):A111.
   Google Scholar
• ULUDAG H, DE VOS P, TRESCO PA: Technology of mammalian cell encapsulation. Adv. Drug Deify. Rev (2000) 42:29–64.
   PubMed Web of Science ®Google Scholar
• POLLOK JM, KOLIN PA, LORENZENM et al.: Islets of Langerhans encapsulated with a tissue-engineered membrane of rat chondrocytes maintain insulin secretion and glucose-insulin feedback for at least 30 days in culture. Transplant. Proc. (2001) 33:1713–1714.
   PubMed Web of Science ®Google Scholar
• CRUISE GM, HEGRE OD, LAMBERTI FV et al.: In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized, poly (ethylene glycol) diacrylate, membranes. Cell Transplant. (1999) 8(3):293–306.
   PubMed Web of Science ®Google Scholar
• LAMBERTI FV, EVANGELISTA RA, BLYSNIUK J, WHEATLEY MA, SEFTON MV: Microencapsulation of mammalian cells in polyacrylates. Appl. Biochem. Biotechnol (1984) 10:101–104.
   PubMed Web of Science ®Google Scholar
• PREVOST P, FLORI S, COLLIER C, MUSCAT E, ROLLAND E: Application of AN69 hydrogel to islet encapsulation. Evaluation in streptozotocin-induced diabetic rat model. Ann. NY Acad. Sci. (1997) 831:344–349.
   PubMed Web of Science ®Google Scholar
• LIM F: Microencapsulation of living mammalian cells. Adv. Biotechnol Proc. (1988) 7:185–197.
   PubMedGoogle Scholar
• SMIDSROD O, SKJAK-BRAEK G: Alginate as immobilization matrix for cells. Trends Biotechnol (1990) 8(3):71–78.
   PubMed Web of Science ®Google Scholar
• PROKOP A, WANG TG: Purification of polymers used for fabrication of an immunoisolation barrier. Ann. NY Acad. Sci. (1997) 831:223–231.
   PubMed Web of Science ®Google Scholar
• KLOCK G, FRANK H, HOUBEN R et al.: Production of purified alginates suitable for use in immunoisolated transplantation. Appl. Microbial. Biotechnol (1994) 40(5):638–643.
   PubMed Web of Science ®Google Scholar
• SOON-SHIONG P, OTTERLIE M, SKJAK-BRAEK Get al: An immunologic basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. (1991) 23(1 Pt 1):758–759.
   Google Scholar
• CLAYTON HA, LONDON NJ, COLLOBY PS, BELL PR, JAMES RF: The effect of capsule composition on the biocompatibility of alginate-poly-L-lysine capsules. J. Microencapsul (1991) 8(2):221–233.
   PubMed Web of Science ®Google Scholar
• ZEKORN T, KLOCK G, HORCHER A et al.: Lymphoid activation by different crude alginates and the effect of purification. Transplant. Proc. (1992) 24(6):2952–2953.
   PubMed Web of Science ®Google Scholar
• DE VOS P, HAMEL AF, TATARKIEWICZ, K: Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia (2002) 45:159–173.
   PubMed Web of Science ®Google Scholar
• DE GROOT M, KEIZER PP, DE HAAN BJ et al.: Microcapsules and their ability to protect islets against cytokine-mediated dysfunction. Transplant. Proc. (2001) 33(1–2):1711–1712.
   Google Scholar
• SOON-SHIONG P, LU ZN, GREWAL I, LANZA R, CLARK W: Prevention of CTL and, NK cell-mediated cytotoxicity by microencapsulation. Horm. Metabol Res. Sapp]. (1990) 25:215–219.
   PubMed Web of Science ®Google Scholar
• SUN AM, O& SHEA GM. GOOSEN MF: Injectable microencapsulated islet cells as a bioartificial pancreas. Appl. Biochem. Biotechnol (1984) 10:87–99.
   PubMed Web of Science ®Google Scholar
• SCHREZENMEIR J, FAUST P, LAUE Cet al.: Immunoprotection by biocompatible membrane permits transplantation of piscine islets to rats. Transplant. Proc. (1989) 21(1):2730–2735.
   Google Scholar
• STRAND BL, RYAN TL, IN'T VELD P et al.: Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. (2001) 10(3):263–275.
   Google Scholar
• DE VOS P, WOLTERS GH, VAN SCHILFGAARDE R: Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant. Proc. (1994) 26(2):782–783.
   PubMed Web of Science ®Google Scholar
• RICKER A, STOCKBERGER S: Hyperimmune response to microencapsulated xenogeneic tissue in NOD mice. Diabetes (1986) 35:61A. Abstract.
   Google Scholar
• GARFINKEL MR, HARLAND RC, OPARA EC: Optimization of the microencapsulated islet for transplantation. Surg. Res. (1998) 76(1):7–10.
   PubMed Web of Science ®Google Scholar
• DARRABIE M, FREEMAN BK, KENDALL WF JR, HOBBS HA, OPARA EC: Durability of sodium sulfate-treated polylysine-alginate microcapsules. Biomed,. Mater. Res. (2001) 54(3):396–399.
   PubMed Web of Science ®Google Scholar
• DE VOS P, VAN STRAATEN JFM, NIEUWENHUIZEN AG et al.: Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes (1999) 48:1381–1388.
   Google Scholar
• LANZA RP, CHICK WL: Transplantation of encapsulated cells and tissues. Surgery (1997) 121:1–9.
   PubMed Web of Science ®Google Scholar
• ZIMMERMANN U, MIMIETZ S, HILL GARTNER M et al.: Hydrogel-based non-autologous cell and tissue therapy. Bio Techniques (2000) 29:564–581.
   Google Scholar
• DUVIVIER-KALI VF, OMER A, PARENT RJ, O'NEILL JJ, WEIR GC: Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes (2001) 50:1698–1705.
   PubMed Web of Science ®Google Scholar
• FRITSCHY WM, VAN STRAATEN JF, DE, VOS P, STRUBBE JH, WOLTERS GH, VAN SCHILFGAARDE R: The efficacy of intraperitoneal pancreatic islet isografts in the reversal of diabetes in rats. Transplantation (1991) 52(5)777–783.
   Google Scholar
• SCHREZENMEIRJ, KIRCHGESSNERJ, GERO L, KUNZ LA, BEYER J, MUELLER-KLIESER W: Effect of microencapsulation on oxygen distribution in islets organs. Transplantation (1994) 57(9):1308–1314.
   PubMed Web of Science ®Google Scholar
• CHICHEPORTICHE D, REACH G: In vitro kinetics of insulin release by microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia (1988) 31:54–57.
   PubMed Web of Science ®Google Scholar
• VAN SCHILFGAARDE, DE VOS P: Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J. MM. Med. (1999) 77:199–205.
   PubMed Web of Science ®Google Scholar
• WONG H, CHANG TM: The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection. Biomater: Artif. Cells Immobilization Biotechnol (1991) 19(4):675–686.
   PubMed Web of Science ®Google Scholar
• CHANG TM: Artificial cells and bioencapsulation in bioartificial organs. Ann. NY Acad. Sci. (1997) 831:249–259.
   PubMed Web of Science ®Google Scholar
• HOBBS HA, KENDALL WF JR, DARRABIE M, OPARA EC: Prevention of morphological changes in alginate microcapsules for islet xenotransplantation. Investig,. Med. (2001) 49(6):572–575.
   PubMed Web of Science ®Google Scholar
• BRISSOVA M, PETRO M, LACIK I, POWERS AC, WANG T: Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal. Biochem. (1996) 242:104–111.
   PubMed Web of Science ®Google Scholar
• COLE DR, WATERFALL M, MCINTYRE M, BAIRD JD: Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia (1992) 35:231–237.
   PubMed Web of Science ®Google Scholar
• THOMAS HE, DARWICHE R, CORBETT JA, KAY TWH: Interleuldn-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes (2002) 51:311–316.
   PubMed Web of Science ®Google Scholar
• CHING CD, HARLAND RC, COLLINS BH, KENDALL W, HOBBS H, OPARA EC: A reliable method for isolation of viable porcine, islet cells. Arch. Surg. (2001) 136:276–279.
   PubMed Web of Science ®Google Scholar
• DAVALLI AM, SCAGLIA L, ZANGEN DH, HOLLISTER J, BONNER-WEIR S, WEIR GC: Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes (1996) 45:1161–1167.
   Google Scholar
• PATIENCE C, TAKEUCHI Y, WEISS RA: Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. (1997) 3:282–286.
   PubMed Web of Science ®Google Scholar
• ••The first report from an in vitro study thatraised the possibility of the transmission of PERV from pigs to humans.
   Google Scholar
• VAN DER LAAN LJW, LOCKEY C, GRIFFETH BC et al.: Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature (2000) 407:90–94.
   Google Scholar
• •A report indicating cross-species transmission of PERV in mice.
   Google Scholar
• HENEINE W, TIBELL A, SWITZER WM et al.: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 352:695–699.
   PubMed Web of Science ®Google Scholar
• •The first report of the inability of PERV to be transmitted from pigs to human recipients of islet cell xenografts.
   Google Scholar
• PARADIS K, LANGFORD G, LONG Z et al.: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science (1999) 285:1236–1241.
   PubMed Web of Science ®Google Scholar
• ••A landmark report of a study showing nopossibility of transmission of PERV from pigs to humans, some of whom had received pig tissues for up to 12 years.
   Google Scholar
• NIEBERT M, ROGEL-GAILLARD C, CHARDON P, TONJES RR: Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells.' Virol. (2002) 76(6):2714–2720.
   PubMed Web of Science ®Google Scholar
• GRAY DWR: An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann. NY Acad. Sri. (2001) 944:226–239.
   PubMed Web of Science ®Google Scholar
• GILL RG: Antigen presentation pathways for immunity to islet transplants: relevance to immunoisolation. Ann. NY Acad. Sci. (1999) 875:255–260.
   PubMed Web of Science ®Google Scholar
• PLATT JL, LINDMAN BJ, CHEN H, SPITALNIK SL, BACH FH: Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation (1990) 50:817–822.
   PubMed Web of Science ®Google Scholar
• RATNER AJ, CANHUI H, PEPINO P et al.: Lymphocyte xenoantigens recognized by preformed antibodies. Transplant. Proc. (1992) 24:583–585.
   PubMed Web of Science ®Google Scholar
• GALILI U: Evolution of alpha 1,3 galactosyltransferase and of the alpha-gal epitope. In: Subcellular Biochemistry, Alpha-gal and Antbgal (Vol. 32). Kluwer Academic/Plenum Publishers, New York (1999).
   Google Scholar
• AUCHINCLOSS H, SACHS DH: Xenogeneic transplantation. Ann. Rev. brununol. (1998) 16:433–470.
   PubMed Web of Science ®Google Scholar
• GILL RG: Use of small animal models for screening immunoisolation approaches to cellular transplantation. Ann. NY Acad. Sri. (2001) 944:35–46.
   PubMed Web of Science ®Google Scholar
• BLISS M: The discovery of insulin. The University of Chicago Press, Chicago (1982).
   Google Scholar